SlideShare una empresa de Scribd logo
1 de 5
Descargar para leer sin conexión
Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Refractory Multiple Myeloma – Pipeline Review, H2 2012


http://www.aarkstore.com/reports/Refractory-Multiple-Myeloma-Pipeline-
Review-H2-2012-220603.html


RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml




Summary

Global Markets Direct’s, Refractory Multiple Myeloma - Pipeline Review, H2 2012,
provides an overview of the Refractory Multiple Myeloma therapeutic pipeline. This
report provides information on the therapeutic development for Refractory Multiple
Myeloma, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Refractory Multiple Myeloma. Refractory Multiple Myeloma -
Pipeline Review, H2 2012 is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites
and industry-specific third party sources, put together by Global Markets Direct’s
team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Refractory Multiple Myeloma.
- A review of the Refractory Multiple Myeloma products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
- Coverage of the Refractory Multiple Myeloma pipeline on the basis of route of
administration and molecule type.

Table of contents:

List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Refractory Multiple Myeloma Overview 11
Therapeutics Development 12
An Overview of Pipeline Products for Refractory Multiple Myeloma 12
Refractory Multiple Myeloma Therapeutics under Development by Companies 14
Refractory Multiple Myeloma Therapeutics under Investigation by
Universities/Institutes 16
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Refractory Multiple Myeloma Therapeutics – Products under Development by
Companies 21
Refractory Multiple Myeloma Therapeutics – Products under Investigation by
Universities/Institutes 22
Companies Involved in Refractory Multiple Myeloma Therapeutics Development 23
Bristol-Myers Squibb Company 23
Abbott Laboratories 24
Eli Lilly and Company 25
Merck & Co., Inc. 26
Piramal Healthcare Limited 27
Millennium Pharmaceuticals, Inc. 28
Cephalon, Inc. 29
ImmunoGen, Inc. 30
Pfizer Inc. 31
Celgene Corporation 32
Onyx Pharmaceuticals, Inc. 33




List of Figures

List of Tables are also include.




For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1




Cholangiocellular Hepatoma – Pipeline Review, H2 2012

Hormone Refractory Breast Cancer – Pipeline Review, H2 2012

Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012

Refractory Multiple Myeloma – Pipeline Review, H2 2012

Epithelial Ovarian Cancer – Pipeline Review, H2 2012

Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H2 2012
B-Cell Leukemia – Pipeline Review, H2 2012

Malignant Neoplasms – Pipeline Review, H2 2012

Recurrent Malignant Glioma – Pipeline Review, H2 2012

Endobronchial Cancer – Pipeline Review, H2 2012

Leiomyosarcoma – Pipeline Review, H2 2012

Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H2 2012

Esophageal Tumor – Pipeline Review, H2 2012

Malignant Pleural Mesothelioma – Pipeline Review, H2 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1



You can also request for sample page of above mention reports on
sample@aarkstore.com




For More details Plz do contact :

Aarkstore Enterprise

Lavanya
Phone:08149852585

Email: enquiry@aarkstore.com

Más contenido relacionado

La actualidad más candente

Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...
Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...
Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...IMARC Group
 
Magnetic Stirrer Market PPT: Trends and Dynamics, Drivers, Competitive lands...
Magnetic Stirrer Market  PPT: Trends and Dynamics, Drivers, Competitive lands...Magnetic Stirrer Market  PPT: Trends and Dynamics, Drivers, Competitive lands...
Magnetic Stirrer Market PPT: Trends and Dynamics, Drivers, Competitive lands...IMARC Group
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088
 
Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...
Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...
Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...IMARC Group
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)Teleosis Institute
 
Digna biotech, s.l. product pipeline analysis
Digna biotech, s.l.   product pipeline analysisDigna biotech, s.l.   product pipeline analysis
Digna biotech, s.l. product pipeline analysisraja1233
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Rose088
 
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...IMARC Group
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088
 
Respiratory devices market
Respiratory devices marketRespiratory devices market
Respiratory devices marketAkshay Shinde
 

La actualidad más candente (20)

Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
 
Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...
Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...
Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...
 
Magnetic Stirrer Market PPT: Trends and Dynamics, Drivers, Competitive lands...
Magnetic Stirrer Market  PPT: Trends and Dynamics, Drivers, Competitive lands...Magnetic Stirrer Market  PPT: Trends and Dynamics, Drivers, Competitive lands...
Magnetic Stirrer Market PPT: Trends and Dynamics, Drivers, Competitive lands...
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
 
Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...
Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...
Global laboratory automation Market PPT 2021-26 | Enhancing Huge Growth and L...
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)
 
Digna biotech, s.l. product pipeline analysis
Digna biotech, s.l.   product pipeline analysisDigna biotech, s.l.   product pipeline analysis
Digna biotech, s.l. product pipeline analysis
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
 
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
 
Respiratory devices market
Respiratory devices marketRespiratory devices market
Respiratory devices market
 

Similar a Refractory multiple myeloma – pipeline review, h2 2012

Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012
Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012
Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012Rose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Ambikabasa
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015Ambikabasa
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Rose088
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015Ambikabasa
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015Ambikabasa
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...ReportsnReports
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015Ambikabasa
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015Ambikabasa
 

Similar a Refractory multiple myeloma – pipeline review, h2 2012 (20)

Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012
Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012
Muscle invasive bladder cancer (mibc) – pipeline review, h2 2012
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012Gastroenteritis – pipeline review, h1 2012
Gastroenteritis – pipeline review, h1 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional P...
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
 
Vulvar Cancer - Pipeline Insight, 2018
Vulvar Cancer - Pipeline Insight, 2018Vulvar Cancer - Pipeline Insight, 2018
Vulvar Cancer - Pipeline Insight, 2018
 

Más de Rose088

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016   robust growth in alternativeIndia wellness industry outlook 2016   robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeRose088
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016Rose088
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineRose088
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Rose088
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals   adoptionDownstream processing in biopharmaceuticals   adoption
Downstream processing in biopharmaceuticals adoptionRose088
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Rose088
 

Más de Rose088 (16)

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016   robust growth in alternativeIndia wellness industry outlook 2016   robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals   adoptionDownstream processing in biopharmaceuticals   adoption
Downstream processing in biopharmaceuticals adoption
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012
 

Último

Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 

Último (20)

GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 

Refractory multiple myeloma – pipeline review, h2 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: Refractory Multiple Myeloma – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Refractory-Multiple-Myeloma-Pipeline- Review-H2-2012-220603.html RSS link of Global Markets Direct http://www.aarkstore.com/feeds/Global-Markets-Direct.xml Summary Global Markets Direct’s, Refractory Multiple Myeloma - Pipeline Review, H2 2012, provides an overview of the Refractory Multiple Myeloma therapeutic pipeline. This report provides information on the therapeutic development for Refractory Multiple Myeloma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Refractory Multiple Myeloma. Refractory Multiple Myeloma - Pipeline Review, H2 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Refractory Multiple Myeloma. - A review of the Refractory Multiple Myeloma products under development by
  • 2. companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Refractory Multiple Myeloma pipeline on the basis of route of administration and molecule type. Table of contents: List of Tables 8 List of Figures 9 Introduction 10 Global Markets Direct Report Coverage 10 Refractory Multiple Myeloma Overview 11 Therapeutics Development 12 An Overview of Pipeline Products for Refractory Multiple Myeloma 12 Refractory Multiple Myeloma Therapeutics under Development by Companies 14 Refractory Multiple Myeloma Therapeutics under Investigation by Universities/Institutes 16 Late Stage Products 18 Comparative Analysis 18 Mid Clinical Stage Products 19 Comparative Analysis 19 Early Clinical Stage Products 20 Comparative Analysis 20 Refractory Multiple Myeloma Therapeutics – Products under Development by Companies 21 Refractory Multiple Myeloma Therapeutics – Products under Investigation by Universities/Institutes 22 Companies Involved in Refractory Multiple Myeloma Therapeutics Development 23 Bristol-Myers Squibb Company 23 Abbott Laboratories 24 Eli Lilly and Company 25 Merck & Co., Inc. 26 Piramal Healthcare Limited 27
  • 3. Millennium Pharmaceuticals, Inc. 28 Cephalon, Inc. 29 ImmunoGen, Inc. 30 Pfizer Inc. 31 Celgene Corporation 32 Onyx Pharmaceuticals, Inc. 33 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H2 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1 Cholangiocellular Hepatoma – Pipeline Review, H2 2012 Hormone Refractory Breast Cancer – Pipeline Review, H2 2012 Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012 Refractory Multiple Myeloma – Pipeline Review, H2 2012 Epithelial Ovarian Cancer – Pipeline Review, H2 2012 Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H2 2012
  • 4. B-Cell Leukemia – Pipeline Review, H2 2012 Malignant Neoplasms – Pipeline Review, H2 2012 Recurrent Malignant Glioma – Pipeline Review, H2 2012 Endobronchial Cancer – Pipeline Review, H2 2012 Leiomyosarcoma – Pipeline Review, H2 2012 Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H2 2012 Esophageal Tumor – Pipeline Review, H2 2012 Malignant Pleural Mesothelioma – Pipeline Review, H2 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 You can also request for sample page of above mention reports on sample@aarkstore.com For More details Plz do contact : Aarkstore Enterprise Lavanya